Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GB-0998 for Steroid-resistant Polymyositis and Dermatomyositis
NCT00335985Phase 3Completed
- Sponsor
- Japan Blood Products Organization
- Start
- Jun 2006
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of intravenous immunoglobulin G in polymyositis (PM) and dermatomyositis (DM) (2 arms), sponsored by Japan Blood Products Organization. Primary endpoint: Manual Muscle Testing scores at 8 weeks. Started Jun 2006; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
polymyositis (PM)dermatomyositis (DM)
Beyond the preview
Go deeper on NCT00335985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335985.